Roundtable Discussion: The Biotech and Medtech Startup Ecosystem (June 2016)
June 2016 BioMelbourne Network in partnership with Allens hosted a roundtable with the Hon Phillip Dalidakis Minister for Small Business, Innovation and Trade on the 20th of June to discuss the biotech and medtech startup ecosystem. Minister Dalidakis…
Updated clinical trial data on CAVATAK™ tumour targeting and immune-activation presented at the American Society Clinical Oncology (ASCO) Annual Meeting
6 June 2016, Sydney, Australia: Viralytics Limited(ASX: VLA, OTC: VRACY) today announced that it has presented posters updating the results of the ongoing Phase 1 STORM/KEYNOTE 200 and the completed Phase 2 CALM clinical trials of Viralytics’ lead…
Melbourne And Boston Strike New Health Agreements
Premier Daniel Andrews today visited the Boston Children’s Hospital as part of his official US visit, announcing a new partnership with Victoria’s Royal Children’s Hospital in Melbourne.As two of the world’s leading children’s hospitals, the Boston and Royal…
Medical researchers warn Australia will lose scientists if funding is not boosted
The society representing Australian medical researchers says the country is at risk of losing high-value scientists to overseas research organisations unless funding for the sector is further increased.In 2015, 13.73 per cent of grant applications to the Federal Government’s National…
Robotic arm that could give amputees the sensation of touch being tested in Melbourne
A robotic arm that could result in amputees regaining their sense of touch and increased movement is the latest breakthrough for Melbourne researchers trying to develop prosthetic limbs that work “like normal”. Key points: Scientists want to send…
Industry/Academia Working Group (May 2016)
May 2016 The BioMelbourne Network Industry/Academia Working group was established to work toward a shared vision for Melbourne as a city with a rich culture of collaboration that fosters industry-academic engagement. The purpose of the group is to…
Clinical/Industry Working Group May (2016)
May 2016 The BioMelbourne Network Clinical/Industry Working Group was established to work toward a shared vision for Melbourne as a world leading location for clinical trials. The purpose of the group is to promote and support Melbourne as…
Gender Equality and Innovation (April 2016)
18 April 2016 It’s time to do things differently in Australia and be bolder in our commitment to diversity, says CEO of the BioMelbourne Network Dr Krystal Evans. SCIENCE MEETS BUSINESS Though Leadership Series. Click here for full…
Federal Budget: Scientists Push for More Research Funding
April 2016 Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest…
Women in STEM and Entrepreneurship Roundtable Discussion
April 2016 In April 2016, Dr Krystal Evans participated in a roundtable discussion on “Women in STEM and Entrepreneurship” in Canberra. The aim of this roundtable was to bring together key representatives from Government, industry, research and education to…
R&D Tax Incentive Review (February 2016)
February 2016 The R&D tax incentive is a highly successful policy programme has helped many Australian biotechnology and medical technology businesses to undertake additional R&D activities and to successfully create innovative health care products for the global export…
Response to Medical Technology and Pharmaceuticals Discussion Paper
September 2015 In September 2015, BioMelbourne Network welcomed the opportunity to contribute to the Medical Technology and Pharmaceuticals Discussion Paper produced by the Victorian Government’s Department of Economic Development, Jobs, Transport and Resources. This Paper formed part of…
